Polpharma European CDMO Partner & API Manufacturer since 1951

Find Senazodan Hydrochloride manufacturers, exporters & distributors on PharmaCompass

Senazodan Hydrochloride

Senazodan Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

1 API Suppliers, 1 USDMF

Product Search

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

EU WC

Listed Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

Also known as: 98326-33-1, Mci-154, Mci 154, Senazodan hcl, Senazodan (hydrochloride), 8aqj5mim3p

Molecular Formula

C₁₅H₁₅ClN₄O

Molecular Weight

302.76 g/mol

InChI Key

NYQCKFLLTCINSJ-UHFFFAOYSA-N

FDA UNII

8AQJ5MIM3P

1 2D Structure

Senazodan Hydrochloride

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

3-[4-(pyridin-4-ylamino)phenyl]-4,5-dihydro-1H-pyridazin-6-one;hydrochloride

2.1.2 InChI

InChI=1S/C15H14N4O.ClH/c20-15-6-5-14(18-19-15)11-1-3-12(4-2-11)17-13-7-9-16-10-8-13;/h1-4,7-10H,5-6H2,(H,16,17)(H,19,20);1H

2.1.3 InChI Key

NYQCKFLLTCINSJ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1CC(=O)NN=C1C2=CC=C(C=C2)NC3=CC=NC=C3.Cl

2.2 Other Identifiers

2.2.1 UNII

8AQJ5MIM3P

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 6-(4-(4'-pyridyl)aminophenyl)-4,5-dihydro-3(2h)-pyridazinone Hydrochloride

2. Mci 154

3. Mci-154

2.3.2 Depositor-Supplied Synonyms

1. 98326-33-1

2. Mci-154

3. Mci 154

4. Senazodan Hcl

5. Senazodan (hydrochloride)

6. 8aqj5mim3p

7. 6-(4-(pyridin-4-ylamino)phenyl)-4,5-dihydropyridazin-3(2h)-one Hydrochloride

8. Unii-8aqj5mim3p

9. 6-(4-(4'-pyridyl)aminophenyl)-4,5-dihydro-3(2h)-pyridazinone Hydrochloride

10. Chembl543966

11. Dtxsid00913328

12. Hy-101693a

13. 3(2h)-pyridazinone, 4,5-dihydro-6-(4-(4-pyridinylamino)phenyl)-, Monohydrochloride

14. 4,5-dihydro-6-(4-(4-pyridinylamino)phenyl)-3(2h)-pyridazinone Monohydrochloride

15. Cs-0033842

16. Q27270120

17. 3-[4-(pyridin-4-ylamino)phenyl]-4,5-dihydro-1h-pyridazin-6-one;hydrochloride

18. 3(2h)-pyridazinone, 4,5-dihydro-6-(4-(4-pyridinylamino)phenyl)-, Hydrochloride (1:1)

19. 6-{4-[(pyridin-4(1h)-ylidene)amino]phenyl}-4,5-dihydropyridazin-3-ol--hydrogen Chloride (1/1)

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₁₅ClN₄O
Molecular Weight	302.76 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	3
Exact Mass	302.0934388 g/mol
Monoisotopic Mass	302.0934388 g/mol
Topological Polar Surface Area	66.4 Å²
Heavy Atom Count	21
Formal Charge	0
Complexity	368
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Cardiotonic Agents

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)